InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.25
(
0.50%
)
Bitcoin
91,368.30
(
0.34%
)
Post# of 13742
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

groverdongles

Send PM Follow Ignore
Followers 14
Posts 1505
Boards Moderated 0
Alias Born 03/30/2021

groverdongles

Re: Rubberneck2 post# 8659

Monday, 07/12/2021 5:30:30 PM

Monday, July 12, 2021 5:30:30 PM

Post# of 13742
IND approval at the very least allows the drugs to be given to human beings for trials in the US. Unfortunately Medolife was told to do animal toxicology studies on Escozine which is quite literally the first study required to do on any drug before it can even be given to humans. Basically the FDA said this drug isn't ready for any human trial yet. They're years away.
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up